EUVIMEDEUVIMED entdecken
Crossref

Lacmoid‐Induced Conformational Changes Inhibit Fibrillation of Human Islet Amyloid Polypeptide

Charu Thapliyal, Prachi Joshi, Masochon Raingam, Rajesh Mishra iD

ChemBioChem · 2025

DOI: 10.1002/cbic.202500383 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemBioChem, 2025. Verfasst von Charu Thapliyal und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Biotechnology, Jawaharlal Nehru University, New Delhi, 110067, India. Hauptthemen laut MEDLINE: Islet Amyloid Polypeptide, Amyloid. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 2 diabetes is a devastating metabolic disorder affecting millions of people worldwide. Deposition of amyloid formed by human islet amyloid polypeptide (IAPP) around pancreatic β‐cells is one of the possible causes of the disease. IAPP is a 37‐residue peptide expressed by the pancreatic β‐cells and cosecreted with insulin, and its misfolding and aggregation into toxic amyloid fibrils are closely linked to β‐cell dysfunction. Herein, it is demonstrated that lacmoid effectively inhibits IAPP fibrillation and disaggregates preformed fibrils. Thioflavin T fluorescence in combination with morphological analysis by atomic force microscopy and transmission electron microscopy confirms complete inhibition and disaggregation of IAPP fibrillation at equimolar concentrations of lacmoid. Additionally, circular dichroism and Fourier transform infrared spectroscopy reveal significant changes in the secondary structure of IAPP during fibrillation in the presence of lacmoid. Cytotoxicity assay in U2OS cells show that lacmoid reduces IAPP fibril‐induced toxicity. Molecular docking studies further reveal that the Asn14 residue of IAPP plays a critical role in its interaction with lacmoid. The findings collectively highlight the importance of lacmoid as an inhibitor of IAPP fibrillation which may have potential to develop as a drug candidate for the treatment of type 2 diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Islet Amyloid PolypeptideAmyloidHumansMolecular Docking SimulationProtein ConformationCell SurvivalProtein Structure, Secondary

Stichwörter der Autor:innen

amyloidfluorescence spectroscopyinfrared spectroscopyislet amyloid polypeptidelacmoid

Substanzen

Islet Amyloid PolypeptideAmyloid

Autor:innen und Institutionen

  • School of Biotechnology, Jawaharlal Nehru University, New Delhi, 110067, India.

ORCID-Profile: Rajesh Mishra

Förderung

  • Indian Council of Medical Research

Zitieren

APA

Thapliyal, C., Joshi, P., Raingam, M., & Mishra, R. (2025). Lacmoid‐Induced Conformational Changes Inhibit Fibrillation of Human Islet Amyloid Polypeptide. ChemBioChem. https://doi.org/10.1002/cbic.202500383

Vancouver

Thapliyal C, Joshi P, Raingam M, Mishra R. Lacmoid‐Induced Conformational Changes Inhibit Fibrillation of Human Islet Amyloid Polypeptide. ChemBioChem. 2025. doi:10.1002/cbic.202500383

BibTeX
@article{Thapliyal2025,
  author = {Thapliyal, Charu and Joshi, Prachi and Raingam, Masochon and Mishra, Rajesh},
  title = {Lacmoid‐Induced Conformational Changes Inhibit Fibrillation of Human Islet Amyloid Polypeptide},
  journal = {ChemBioChem},
  year = {2025},
  doi = {10.1002/cbic.202500383}
}
Kostenlos starten →